Am J Physiol Cell Physiol Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Cell Physiol 267: C865-C868, 1994;
0363-6143/94 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeman, R. J.
Right arrow Articles by Etlinger, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeman, R. J.
Right arrow Articles by Etlinger, J. D.

AJP - Cell Physiology, Vol 267, Issue 3 C865-C868, Copyright © 1994 by American Physiological Society

ARTICLES

Clenbuterol, a beta 2-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle

R. J. Zeman, Y. Zhang and J. D. Etlinger
Department of Cell Biology and Anatomy, New York Medical College, Valhalla 10595.

Treatment with the adrenergic beta 2-receptor agonist clenbuterol prevented, in dystrophic muscle from mdx mice, a pronounced loss of contractile strength that is observed after blockade of muscle regeneration with gamma irradiation. In addition, muscle mass and myosin content were greater (62-109%) in irradiated hindlimbs from clenbuterol-treated mdx mice, whereas the effects of the beta 2-agonist were relatively smaller (12-21%) in the nonirradiated hindlimbs. Together, these results suggest that beta 2-agonists can antagonize degenerative processes occurring in muscle fibers lacking dystrophin.


This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
G. S. Lynch and J. G. Ryall
Role of {beta}-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease
Physiol Rev, April 1, 2008; 88(2): 729 - 767.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
J. J. McCarthy and K. A. Esser
Counterpoint: Satellite cell addition is not obligatory for skeletal muscle hypertrophy
J Appl Physiol, September 1, 2007; 103(3): 1100 - 1102.
[Full Text] [PDF]

Home page
 Exp PhysiolHome page
M. A. Pellegrino, G. D'Antona, S. Bortolotto, F. Boschi, O. Pastoris, R. Bottinelli, B. Polla, and C. Reggiani
Clenbuterol antagonizes glucocorticoid-induced atrophy and fibre type transformation in mice
Exp Physiol, January 1, 2004; 89(1): 89 - 100.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. E. Mozdziak, M. L. Greaser, and E. Schultz
Myogenin, MyoD, and myosin expression after pharmacologically and surgically induced hypertrophy
J Appl Physiol, April 1, 1998; 84(4): 1359 - 1364.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Hayes and D. A. Williams
Contractile properties of clenbuterol-treated mdx muscle are enhanced by low-intensity swimming
J Appl Physiol, February 1, 1997; 82(2): 435 - 439.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online